Dabur India Projects Double-Digit Revenue and PAT Growth in Q2 FY27
Dabur India Ltd 路 Others (Uncategorized) 路 06 Oct 2026, 6:20 pm
Dabur India Projects Double-Digit Revenue and PAT Growth in Q2 FY27 Dabur India expects consolidated revenue and PAT to grow in double digits for the quarter ended 30th Sep'26 (Q2 FY27). The India FMCG business is set to accelerate to double-digit growth, driven by double-digit gains in Home & Personal Care and mid-teens growth in Food & Beverages. Healthcare expects mid-single-digit growth, while International Business projects high-teens INR growth despite Middle East headwinds. Operating margins faced commodity inflation pressures, partially offset by calibrated price hikes and cost initiatives. Emerging channels and rural markets continued to outpace urban general trade.
Original exchange filing (PDF)
More announcements from Dabur India Ltd
- Re-affirmation of Credit Rating by CRISIL Ratings Limited 路 17 Nov 2026
- Change in Senior Management Personnel of the Company 路 14 Nov 2026
- Closure of Dabur International Limited, United Kingdom Branch, a branch of the wholly owned subsidiary of the Company. 路 14 Nov 2026
- Submission of information under Regulation 30(5) of the SEBI (LODR) Regulations, 2015 路 13 Nov 2026
- Dissolution of Dabur Pars LLC a subsidiary of Dabur International Limited, a wholly owned subsidiary of the Company. 路 11 Nov 2026
- Closure of Atlanta Body and Health Products (Pty) Ltd., a wholly owned subsidiary of Dermoviva Skin Essentials Inc. a step down subsidiary of the Company. 路 10 Nov 2026
- Transcript of Analyst/ Institutional Investor Meet held on November 05, 2026 路 10 Nov 2026
- Receipt of administrative warning letter from SEBI 路 06 Nov 2026
